FDA NDC
Erzofri extended-release
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 72526-108
- Proprietary name
- Erzofri extended-release
- Nonproprietary name
- paliperidone palmitate
- Labeler
- Shandong Luye Pharmaceutical Co., Ltd.
- Dosage form
- INJECTION
- Strength
- 156 mg/mL
Run it in Rivvi
Which 2027 plans near you dropped or restricted paliperidone palmitate?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.